ClearBridge Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $14M | Sell |
|
|||||
|
2024
Q4 | $13.8M | Sell |
|
|||||
|
2024
Q3 | $17.2M | Sell |
|
|||||
|
2024
Q2 | $21.4M | Sell |
|
|||||
|
2024
Q1 | $22.8M | Sell |
|
|||||
|
2023
Q4 | $26.1M | Sell |
|
|||||
|
2023
Q3 | $38.2M | Sell |
|
|||||
|
2023
Q2 | $37.5M | Sell |
|
|||||
|
2023
Q1 | $45.8M | Sell |
|
|||||
|
2022
Q4 | $114M | Sell |
|
|||||
|
2022
Q3 | $99.5M | Buy |
|
|||||
|
2022
Q2 | $93.2M | Sell |
|
|||||
|
2022
Q1 | $163M | Sell |
|
|||||
|
2021
Q4 | $465M | Buy |
|
|||||
|
2021
Q3 | $401M | Buy |
|
|||||
|
2021
Q2 | $423M | Buy |
|
|||||
|
2021
Q1 | $378M | Sell |
|
|||||
|
2020
Q4 | $528M | Sell |
|
|||||
|
2020
Q3 | $470M | Buy |
|
|||||
|
2020
Q2 | $729M | Sell |
|
|||||
|
2020
Q1 | $534M | Buy |
|
|||||
|
2019
Q4 | $521M | Buy |
|
|||||
|
2019
Q3 | $407M | Buy |
|
|||||
|
2019
Q2 | $512M | Buy |
|
|||||
|
2019
Q1 | $445M | Buy |
|
|||||
|
2018
Q4 | $384M | Buy |
|
|||||
|
2018
Q3 | $393M | Buy |
|
|||||
|
2018
Q2 | $346M | Buy |
|
|||||
|
2018
Q1 | $115M | Buy |
|
|||||
|
2017
Q4 | $120M | Sell |
|
|||||
|
2017
Q3 | $129M | Buy |
|
|||||
|
2017
Q2 | $123M | Buy |
|
|||||
|
2017
Q1 | $117M | Buy |
|
|||||
|
2016
Q4 | $67.6M | Buy |
|
|||||
|
2016
Q3 | $67.1M | Buy |
|
|||||
|
2016
Q2 | $50.5M | Buy |
|
|||||
|
2016
Q1 | $52.4M | Buy |
|
|||||
|
2015
Q4 | $59.6M | Sell |
|
|||||
|
2015
Q3 | $66.2M | Sell |
|
|||||
|
2015
Q2 | $88.8M | Buy |
|
|||||
|
2015
Q1 | $73.3M | Sell |
|
|||||
|
2014
Q4 | $63.2M | Sell |
|
|||||
|
2014
Q3 | $55M | Sell |
|
|||||
|
2014
Q2 | $47.7M | Sell |
|
|||||
|
2014
Q1 | $52.5M | Sell |
|
|||||
|
2013
Q4 | $56.7M | Buy |
|
|||||
|
2013
Q3 | $51.1M | Buy |
|
|||||
|
2013
Q2 | $25M | Buy |
|